(R-trans, R’-trans)-Atracurium

(R trans, R trans) Atracurium or (1R,1’R,2S,2’S)-2,2′-((pentane-1,5-diylbis(oxy))bis(3-oxopropane-3,1-diyl))bis(1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium) 2,2,2-trifluoroacetate, it is a non-depolarizing neuromuscular blocking drug of the benzylisoquinolinium class which is used for adjunct to general anaesthesia during surgery to relax skeletal muscles

Additional information

Catalogue No.

VE008038

CAS No.

N/A

Molecular Formula

C57H72F6N2O16

Molecular Weight

1155.18 g/mol

IUPAC Name

(1R, 1'R, 2S, 2'S)-2, 2'-((pentane-1, 5-diylbis(oxy))bis(3-oxopropane-3, 1-diyl))bis(1-(3, 4-dimethoxybenzyl)-6, 7-dimethoxy-2-methyl-1, 2, 3, 4-tetrahydroisoquinolin-2-ium) 2, 2, 2-trifluoroacetate

References

Chalermkitpanit, Pornpan, et al. “Determination of Dose and Efficacy of Atracurium for Rapid Sequence Induction of Anesthesia: A Randomised Prospective Study.” Journal of Anaesthesiology, Clinical Pharmacology, vol. 36, no. 1, 2020, pp. 37–42, http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7047700/, 10.4103/joacp.JOACP_36_19. Accessed 26 Jan. 2022.

Status

In-stock